• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌监测的促进因素和障碍综述——定性研究结果的系统评价

Synthesising enablers and barriers to hepatocellular carcinoma surveillance-A systematic review of qualitative findings.

作者信息

Moussa Dina, Flores Joan Ericka, Doyle Joseph S, Ryan Marno, Wallace Jack, Howell Jessica

机构信息

University of Melbourne, Australia.

St Vincent's Hospital Melbourne, Australia.

出版信息

PLoS One. 2025 Jan 10;20(1):e0313216. doi: 10.1371/journal.pone.0313216. eCollection 2025.

DOI:10.1371/journal.pone.0313216
PMID:39792827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11723554/
Abstract

BACKGROUND & AIMS: This systematic literature review of qualitative findings aims to identify the perceived barriers and enablers for hepatocellular carcinoma (HCC) surveillance from patient and clinician perspectives.

METHODS

A systematic search of databases using key term combinations with the following inclusion criteria: 1) qualitative and quantitative (survey) studies exploring barriers and enablers of HCC surveillance, and 2) qualitative and quantitative (survey) studies exploring barriers and enablers of enagagement in clinical care for patients with cirrhosis and/or viral hepatitis.

RESULTS

The search returned 445 citations: 371 did not meet the study criteria and were excluded. 74 studies proceeded to full-text review, leading to 21 included studies (15 studies from searching with a further six studies from citation review) progressing to data extraction by two independent reviewers. Results from studies exploring patients' perspectives reinforce that barriers are experienced by patients across different health settings, cultures, and regions. Logistical barriers including costs and transportation, and knowledge/awareness barriers were commonly identified. Studies that included clinician perspectives highlighted the need for healthcare provider education and system-level interventions to optimize HCC surveillance uptake in clinical practice.

CONCLUSION

These findings highlight the critical need for interventions that enable engagement in HCC surveillance in health services.

摘要

背景与目的

本项对定性研究结果的系统文献综述旨在从患者和临床医生的角度确定肝细胞癌(HCC)监测中存在的感知障碍和促进因素。

方法

使用关键词组合对数据库进行系统检索,纳入标准如下:1)探索HCC监测障碍和促进因素的定性和定量(调查)研究,以及2)探索肝硬化和/或病毒性肝炎患者临床护理参与障碍和促进因素的定性和定量(调查)研究。

结果

检索共返回445条引文:371条不符合研究标准被排除。74项研究进入全文审查,最终21项研究(检索得到15项研究,引文审查又得到6项研究)由两名独立审查员进行数据提取。探索患者观点的研究结果强化了这样的观点,即不同健康环境、文化和地区的患者都面临障碍。常见的障碍包括后勤方面的障碍,如成本和交通,以及知识/意识方面的障碍。纳入临床医生观点的研究强调,需要对医疗服务提供者进行教育,并采取系统层面的干预措施,以优化临床实践中HCC监测的应用。

结论

这些发现凸显了在卫生服务中开展促进HCC监测参与的干预措施的迫切需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/129d/11723554/0244ebbc5d5b/pone.0313216.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/129d/11723554/7b83fc65e12f/pone.0313216.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/129d/11723554/0244ebbc5d5b/pone.0313216.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/129d/11723554/7b83fc65e12f/pone.0313216.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/129d/11723554/0244ebbc5d5b/pone.0313216.g002.jpg

相似文献

1
Synthesising enablers and barriers to hepatocellular carcinoma surveillance-A systematic review of qualitative findings.肝细胞癌监测的促进因素和障碍综述——定性研究结果的系统评价
PLoS One. 2025 Jan 10;20(1):e0313216. doi: 10.1371/journal.pone.0313216. eCollection 2025.
2
Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance.临床医生对肝细胞癌监测的认知和障碍。
JAMA Netw Open. 2024 May 1;7(5):e2411076. doi: 10.1001/jamanetworkopen.2024.11076.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.美国高危人群肝癌监测的患者、提供者和系统层面障碍:范围综述。
J Gastrointest Cancer. 2023 Jun;54(2):332-356. doi: 10.1007/s12029-022-00851-x. Epub 2022 Jul 26.
5
Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.患者报告的障碍与肝硬化患者较低的肝细胞癌监测率相关。
Hepatology. 2017 Mar;65(3):875-884. doi: 10.1002/hep.28770. Epub 2016 Oct 1.
6
Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.基层医疗服务提供者的实践模式与态度以及肝硬化患者肝细胞癌监测的障碍
Clin Gastroenterol Hepatol. 2015 Apr;13(4):791-8.e1. doi: 10.1016/j.cgh.2014.06.031. Epub 2014 Jul 11.
7
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.患者报告的障碍与肝硬化患者多中心队列中接受肝细胞癌监测的情况相关。
Clin Gastroenterol Hepatol. 2021 May;19(5):987-995.e1. doi: 10.1016/j.cgh.2020.06.049. Epub 2020 Jul 3.
8
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
9
Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.初级保健提供者的实践模式及肝癌监测的障碍。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):766-773. doi: 10.1016/j.cgh.2018.07.029. Epub 2018 Jul 26.
10
Health professionals' views on the barriers and enablers to evidence-based practice for acute stroke care: a systematic review.医疗专业人员对急性中风护理循证实践的障碍与促进因素的看法:一项系统综述
Implement Sci. 2017 Jun 5;12(1):74. doi: 10.1186/s13012-017-0599-3.

本文引用的文献

1
Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals.肝细胞癌的临床护理:肿瘤专业人员经验和挑战的混合方法评估。
Cancer Med. 2023 Feb;12(3):3670-3683. doi: 10.1002/cam4.5216. Epub 2022 Sep 15.
2
Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.医患报告的肝细胞癌监测障碍:一项全国性调查。
Medicine (Baltimore). 2022 Sep 9;101(36):e30538. doi: 10.1097/MD.0000000000030538.
3
Hepatocellular carcinoma screening practices among patients with chronic hepatitis B by Canadian gastroenterologists and hepatologists: An online survey.
加拿大胃肠病学家和肝病学家对慢性乙型肝炎患者进行肝细胞癌筛查的实践:一项在线调查。
Can Liver J. 2019 Dec 10;2(4):199-209. doi: 10.3138/canlivj.2019-0012. eCollection 2019 Fall.
4
Australian consensus recommendations for the management of hepatitis B.澳大利亚乙型肝炎管理共识建议
Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6.
5
'We can bear it!' Unpacking barriers to hepatocellular carcinoma screening among patients with hepatitis B: A qualitative study.“我们能承受!”剖析乙肝患者肝细胞癌筛查的障碍:一项定性研究
J Clin Nurs. 2022 Nov;31(21-22):3130-3143. doi: 10.1111/jocn.16140. Epub 2021 Nov 23.
6
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐:2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
7
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.应对全球肝细胞癌:流行病学、预防与管理
J Gastrointest Oncol. 2021 Jul;12(Suppl 2):S361-S373. doi: 10.21037/jgo.2020.02.08.
8
Surveillance of patients with cirrhosis remains suboptimal in the United States.在美国,对肝硬化患者的监测仍未达到最佳状态。
J Hepatol. 2021 Oct;75(4):856-864. doi: 10.1016/j.jhep.2021.04.042. Epub 2021 May 7.
9
Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.筛查可降低慢性乙型肝炎患者肝细胞癌相关死亡率。
J Hepatol. 2021 Apr;74(4):850-859. doi: 10.1016/j.jhep.2020.11.023. Epub 2020 Nov 24.
10
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.美国肝硬化患者基于风险的肝细胞癌监测的提供者态度。
Clin Gastroenterol Hepatol. 2022 Jan;20(1):183-193. doi: 10.1016/j.cgh.2020.09.015. Epub 2020 Sep 12.